Track the Shanghai MicroPort MedBot (Group) Co., Ltd. - B stock price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares trade on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Shanghai MicroPort MedBot (Group) Co., Ltd. - B has published 1 public disclosures. Market capitalisation: €21.4bn. The latest transaction was filed on 9 April 2026 (Purchase). Among the most active insiders: Liang Min. Every trade is openly available.
Analysts rate Shanghai MicroPort MedBot (Group) Co., Ltd. - B Strong Buy (bullish), based on 10 analysts. Average price target: HK$36.15.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Shanghai MicroPort MedBot (Group) Co., Ltd. is a company focused on the development of medical technologies and surgical robots. It is listed on the Hong Kong Stock Exchange.